TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/2/20 19:27 | 2/28/20 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Amello Jason | MA | O | SVP,CFO, | S.d | -61 | 8.70 | 0 | -7 | -5 | 145 | D | ||||||||||||||
9/2/10 11:45 | 8/31/10 | GENZ | Genzyme Corp | MA | Health | BioPrd | Biological Products, (No Diag | Amello Jason | MA | O | Corp Con | S.d | -467 | 70.30 | 0 | -7 | -67 | 3 | D | ||||||||||||||
5/26/10 17:42 | 5/25/10 | GENZ | Genzyme Corp | MA | Health | BioPrd | Biological Products, (No Diag | Amello Jason | MA | O | CorpCont | S.d | -24 | 45.62 | 0 | -1 | -14 | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |